Amanote Research
Register
Sign In
Toll-Like Receptor 9 (TLR9) or TLR3 Adjuvants to Promote Cancer Vaccine–induced Effector T Cell Expansion
Science-Business eXchange
doi 10.1038/scibx.2013.1207
Full Text
Open PDF
Abstract
Available in
full text
Date
October 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
CD8; Interferon-Α (IFN-α); Toll-Like Receptor 9 (TLR9)
Science-Business eXchange
Ammonia-Induced Brain Edema Requires Macrophage and T Cell Expression of Toll-Like Receptor 9
Cellular and Molecular Gastroenterology and Hepatology
Hepatology
Gastroenterology
Toll Like Receptor-9 Mediated Invasion in Breast Cancer
Toll Like Receptor-9 Mediated Invasion in Breast Cancer
Corrigendum: Ligand-Induced Conformational Changes Allosterically Activate Toll-Like Receptor 9
Nature Immunology
Allergy
Immunology
Escherichia Coli Nissle 1917 Distinctively Modulates T-Cell Cycling and Expansion via Toll-Like Receptor 2 Signaling
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Toll-Like Receptor-9 Is Involved in the Development of B Cell Stimulating Factor-Induced Systemic Lupus Erythematosus
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Human Papillomavirus (HPV) Deregulation of Toll-Like Receptor 9
OncoImmunology
Oncology
Allergy
Immunology
Toll-Like Receptor 9 in Plasmacytoid Dendritic Cells Fails to Detect Parvoviruses
Journal of Virology
Insect Science
Immunology
Microbiology
Virology